To publish or not to publish

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    Anonymous Nat. Biotechnol. 38, 1 (2020).

  2. 2.

    National Academies of Sciences, Engineering, and Medicine. Second International Summit on Human Genome Editing: Continuing the Global Discussion: Proceedings of a Workshop—in Brief (National Academies Press, 2019); https://doi.org/10.17226/25343.

  3. 3.

    Regalado, A. China’s CRISPR babies: Read exclusive excerpts from the unseen original research. MIT Technology Review (3 December 2019); https://www.technologyreview.com/s/614764/chinas-crispr-babies-read-exclusive-excerpts-he-jiankui-paper/

  4. 4.

    Musunuru, K. Opinion: we need to know what happened to CRISPR twins Lulu and Nana. MIT Technology Review (3 December 2019); https://www.technologyreview.com/s/614762/crispr-baby-twins-lulu-and-nana-what-happened/

  5. 5.

    Berger, R. L. N. Engl. J. Med. 322, 1435–1440 (1990).

  6. 6.

    Freedman, B. in When Medicine Went Mad: Bioethics and the Holocaust (ed. Caplan, A.) 141–154 (Humana Press, 1992).

Download references

Author information

Correspondence to Françoise Baylis.

Ethics declarations

Competing interests

F.B. is a member of the WHO Expert Advisory Committee on Developing Global Standards for Governance and Oversight of Human Genome Editing, and also the author of Altered Inheritance: CRISPR and the Ethics of Human Genome Editing.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Baylis, F. To publish or not to publish. Nat Biotechnol (2020). https://doi.org/10.1038/s41587-020-0435-1

Download citation